In April 2024, the New England Journal of Medicine published results of a Phase 2 clinical trial of a diabetes drug lixisenatide, testing whether the medication could slow progression of Parkinson’s…

Categories : WEBINARS

Learn more 

Leave a Reply

Your email address will not be published. Required fields are marked *

copyright 2021